Identification of Chemical Probes Targeting MBD2.

Area of Science:

• Epigenetics and Molecular Biology
• Chemical Biology
• Structural Biology

Background:

• Epigenetic modifications, particularly DNA methylation, play crucial roles in cellular function and disease.
• Understanding how epigenetic marks are recognized (read) by proteins is essential for deciphering cellular responses.
• Methyl-CpG binding domain proteins (MBDs) are key readers of DNA methylation, but their precise mechanisms are not fully understood.

Purpose of the Study:

• To design and validate chemical probes targeting the methyl-CpG reader protein, human MBD2.
• To investigate the interaction between MBD2 and its DNA binding partners.
• To provide starting points for developing potent chemical probes for MBD proteins.

Main Methods:

• Design of 5-methylcytosine analogues as potential ligands.
• Protein thermal shift assay and AlphaScreen to identify MBD2 binders.
• Two-dimensional NMR spectroscopy and virtual docking to elucidate ligand-protein interactions.

Main Results:

• Identified three small molecule fragments that bind to human MBD2.
• Demonstrated that these fragments disrupt the interaction between MBD2 and methylated DNA.
• Structural studies revealed that the compounds bind to key residues involved in DNA recognition.

Conclusions:

• Developed novel chemical probes for studying MBD proteins.
• These probes provide valuable insights into the mechanism of MBD2-mediated DNA methylation recognition.
• The identified fragments serve as a foundation for creating more potent chemical tools for epigenetic research.